| Autor: |
Martín Roldán, Alicia, Alarcón-Payer, Carolina, Sánchez Suárez, María Del Mar, Jiménez Morales, Alberto |
| Zdroj: |
Anti-Cancer Drugs; October 2024, Vol. 35 Issue: 9 p872-874, 3p |
| Abstrakt: |
We present a case of a patient diagnosed with FLT3 mut+ acute myeloid leukemia with FLT3 and NMP1 mutations who did not respond to standard induction and consolidation treatment with chemotherapy. Due to the FLT3mut+ gene mutation and intermediate cytogenetic risk, treatment with gilteritinib is requested. After treatment she experienced a neutrophilic dermatosis and granuloma annulare that was resolved with gilteritinib dose reduction and specific treatment in coordination with the dermatology department. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
